Tinholt et al. analysed a cohort of 1100 breast cancer samples from TCGA and found that the expression of F5 mRNA was about 2-fold higher in breast tumours compared to normal tissues, and its expression increased in patients with late stage tumours [7]. This evidence concerns the gene F5 and neoplasm.